We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Totally Plc | LSE:TLY | London | Ordinary Share | GB00BYM1JJ00 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.75 | 4.50 | 5.00 | 4.75 | 4.75 | 4.75 | 256,997 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Newspaper:pubg, Pubg & Print | 135.7M | 1.78M | 0.0091 | 5.22 | 9.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/7/2022 14:22 | Really really poor from AllenbyCounting the cash and ignoring theliabilitiesThat's like me looking at my current account and ignoring the massive credit card balance | apatel21 | |
12/7/2022 13:55 | What was growth excluding acquisitions?I see margins are falling a bitNet current assets have gone from minus £4m to minus £14mP/E > 50 ? | apatel21 | |
12/7/2022 13:44 | John, There's a link in my header for Allenby.. "Following a significant upgrade to forecasts in April 2022, Totally delivered preliminary results for the year ended March 2022 that were ahead of our revised expectations. This is a remarkable result given the continuing challenges affecting the healthcare market and the delivery of services. We see many opportunities for further growth over the next three years and this is reflected in our forecasts which now include projections for FY25. With macro-economic and political headwinds increasing almost daily we consider that an investment in Totally offers strong growth with significantly lower risk than many other businesses. We therefore continue to believe that a fair value of 75p is achievable over the forecast period." "Low risk investment – We consider Totally to be a relatively low risk investment with the government being the primary customer through the NHS, an important consideration during a period of increasing financial, macro-economic and political upheavals. With another record year in prospect and c.8p per share of cash (17% of the share price) on the balance sheet, we continue to believe that fair value of 75p is achievable. | sikhthetech | |
12/7/2022 13:39 | Has there been any updated broker coverage today? | johndoe23 | |
12/7/2022 11:15 | Great results, above expectations... lots of new contracts and contract extensions.. Revenue £127.4m(2021: £113.7m) Ebitda £6.2m (£5m) Cash £15.3m (£14.8m) | sikhthetech | |
12/7/2022 10:17 | The steady increase in outsourcing should help margins as that is the part with highest margins, over 30% from memory! | nobbygnome | |
12/7/2022 09:46 | The only question is whether margins will rise or fall and their ability to pass on labour increases. | nigeldoug1 | |
12/7/2022 09:12 | Yes looks good | hybrasil | |
12/7/2022 09:03 | The company does generate cashflow but to arrive at an accounting profit there needs to be a charge for the amount of goodwill paid to acquire the businesses that Totally acquired in the past. Once that is deducted then accounting profits are not great. | quazie12 | |
12/7/2022 08:54 | Check the P/E ratio ! | quazie12 | |
12/7/2022 08:24 | Why are ppl selling with these results ? | kenbos | |
12/7/2022 08:00 | These results should keep the doubters at bay. Well done to Wendy and the board. Importantly, we should see the acquisitions add to the mix next year. We need to keep an eye on the margins, but let's not forget that there is no debt, substantial cash in the bank for safety and further acquisitions. Glad I added recently. | 2vdm | |
12/7/2022 07:36 | An increase in cash also despite paying out close to £1.5 million in dividends in the last financial year | nobbygnome | |
12/7/2022 07:27 | A strong set of record results, debt free, and despite acquisitions, yet another increase in cash. Good dividend, revenues continuing to rise and over 2.5 million users, which both underpins and expands this business's growing footprint in every part of modern healthcare, and improves public awareness of the value and quality TLY have to offer.Acquisitions really showing their worth with rapid margin and turnover expansion, justifying the company's buy and build ethos.Partnering the NHS to help work through its five year backlog, and I don't think there can be many who doubt TLY will continue to expand successfully from here. | microscope | |
12/7/2022 07:25 | Doubling the dividend...whats not to like? | nigeldoug1 | |
12/7/2022 07:11 | On a first quick read the results look extremely good and of course we are guaranteed a jump up in revenue this year as we get a full year of the 2 new acquisitions. There should also be further impressive growth from outsourcing to shorten waiting lists around the country and Ireland. Plus of course a 1p dividend which even at the current share price is above 2%. | nobbygnome | |
11/7/2022 15:02 | Tomorrow could be a flyer, excited to see how well we've done and for the share price to reflect that. GlA | doobz | |
11/7/2022 13:48 | Buying coming in at full ask | johndoe23 | |
11/7/2022 13:11 | Only about £80k worth of shares traded today. Surprisingly little | hybrasil | |
11/7/2022 12:57 | Not long now to buy ahead of the results tomorrow. I suspect the outlook for this year may be rather impressive… | nobbygnome | |
08/7/2022 17:54 | True, true. | longshanks | |
08/7/2022 16:56 | Tuesday :) | spursspurs | |
08/7/2022 15:49 | I have managed to buy some, but needed a NT. IMO, the market has put a lock down on this ahead of what will most likely be a very positive update on Monday. | longshanks |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions